Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2004 Feb 13;303(5660):954-5.
doi: 10.1126/science.303.5660.954c.

Thailand's Prime-Boost HIV Vaccine Phase III

Charal Trinvuthipong
Comment

Thailand's Prime-Boost HIV Vaccine Phase III

Charal Trinvuthipong. Science. .
No abstract available

PubMed Disclaimer

Comment on

  • Public health. A sound rationale needed for phase III HIV-1 vaccine trials.
    Burton DR, Desrosiers RC, Doms RW, Feinberg MB, Gallo RC, Hahn B, Hoxie JA, Hunter E, Korber B, Landay A, Lederman MM, Lieberman J, McCune JM, Moore JP, Nathanson N, Picker L, Richman D, Rinaldo C, Stevenson M, Watkins DI, Wolinsky SM, Zack JA. Burton DR, et al. Science. 2004 Jan 16;303(5656):316. doi: 10.1126/science.1094620. Science. 2004. PMID: 14726576 No abstract available.
  • Policy rebuttal. HIV vaccine trial justified.
    McNeil JG, Johnston MI, Birx DL, Tramont EC. McNeil JG, et al. Science. 2004 Feb 13;303(5660):961. doi: 10.1126/science.1096161. Science. 2004. PMID: 14963313 No abstract available.

Similar articles

  • Policy rebuttal. HIV vaccine trial justified.
    McNeil JG, Johnston MI, Birx DL, Tramont EC. McNeil JG, et al. Science. 2004 Feb 13;303(5660):961. doi: 10.1126/science.1096161. Science. 2004. PMID: 14963313 No abstract available.
  • Public health. A sound rationale needed for phase III HIV-1 vaccine trials.
    Burton DR, Desrosiers RC, Doms RW, Feinberg MB, Gallo RC, Hahn B, Hoxie JA, Hunter E, Korber B, Landay A, Lederman MM, Lieberman J, McCune JM, Moore JP, Nathanson N, Picker L, Richman D, Rinaldo C, Stevenson M, Watkins DI, Wolinsky SM, Zack JA. Burton DR, et al. Science. 2004 Jan 16;303(5656):316. doi: 10.1126/science.1094620. Science. 2004. PMID: 14726576 No abstract available.
  • Support for the RV144 HIV vaccine trial.
    Belshe R, Franchini G, Girard MP, Gotch F, Kaleebu P, Marthas ML, McChesney MB, McCullough R, Mhalu F, Salmon-Ceron D, Sekaly RP, van Rompay K, Verrier B, Wahren B, Weissenbacher M. Belshe R, et al. Science. 2004 Jul 9;305(5681):177-80; author reply 177-80. doi: 10.1126/science.305.5681.177b. Science. 2004. PMID: 15247455 No abstract available.
  • HIV/AIDS preventive vaccine 'prime-boost' phase III trial: foundations and initial lessons learned from Thailand.
    Rerks-Ngarm S, Brown AE, Khamboonruang C, Thongcharoen P, Kunasol P. Rerks-Ngarm S, et al. AIDS. 2006 Jul 13;20(11):1471-9. doi: 10.1097/01.aids.0000237362.26370.f8. AIDS. 2006. PMID: 16847401 Review. No abstract available.
  • Prime-boost immunization strategies against HIV.
    Barnett SW, Klinger JM, Doe B, Walker CM, Hansen L, Duliège AM, Sinangil FM. Barnett SW, et al. AIDS Res Hum Retroviruses. 1998 Oct;14 Suppl 3:S299-309. AIDS Res Hum Retroviruses. 1998. PMID: 9814958 Review. No abstract available.
See all similar articles

Cited by

MeSH terms

LinkOut - more resources